Abstract
Recent experimental interest has centered on the role of the calcium antagonists in the preservation of tissue function due to their ability to inhibit intracellular calcium accumulation as well as their potent vasodilatory properties. Most studies to date have centered primarily on myocardial tissue rendered either ischemic or anoxic by coronary artery ligation or manipulation of perfusing solutions. Assessment of myocardial function has included the quantitation of infarct size,1 ultrastructural histologic changes,2 or the evaluation of cellular biochemical parameters such as measurement of high energy phosphates,3 intracellular pH,4 and pyridine nucleotides.5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bush LR, Romson JL, Ash JL, Lucchesi BR. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J. Cardiovas. Pharmacol., 4 (2): 285–296, 1982.
Fujiwara H, Ashra M, Millard RW, Sato S, Schwartz A. Effects of diltiazem, a calcium channel inhibitor, in retarding cellular damage produced during early myocardial ischemia in pigs: a morphometric and ultrastructural analysis. JACC, 3 (6): 1427–37, June 1984.
Ashraf M, Onda M, Benedict J, Millard R. Prevention of calcium paradox-related myocardial cell injury with diltiazem, a calcium channel blocking agent. Am. J. Cardiol., 49: 1675 1681, May 1982.
Ishihara K, Abiko Y. Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart. J. Pharmacol. Exp. Ther., 222 (3): 720–725, 1982.
Kissin I, Kilpatrick J. Effect of nifedipine on myocardial energy balance in experimental coronary vasoconstriction and occlusion. J. Cardiovasc. Pharmacol., 4 (1): 111–115, 1982.
Burch R, Halushka P. Verapamil inhibition of vasopressinstimulated water flow: possible role of intracellular calcium. J. Pharmacol. Exp. Ther., 226 (3): 701–705, 1983.
Cooper C, Malik K. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J. Pharmacol. Exp. Ther., 229 (1): 139–147, 1983.
Hof R,Iiof A, Neumann P. Effects of PY 108–068, a new calcium channel blocker on general haemodynamics and regional blood flow in anaesthetized cats. A comparison with nifedipine. J. Cardiovasc. Pharmacol., 4: 352–362.
Hof RP. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem. Am. J. Pharmacol., 78: 375–394, 1983.
Wilson PD, Schrier RW. An in vitro model of acute renal failure: calcium restriction protects against ischemic cell death in cultured nephron segments. Clin. Res., 32: 460A, 1984.
Bakris GL, Larson TS, Burnett JC. The protective role of verapamil against rapid contrast-induced intrarenal vasconstriction. Clin. Res., 32: 440A, 1984.
Chance B. Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria. Circ. Res., 38 (1): 31–38, 1976.
Sugano T, Oshino N, Chance B. Mitochondrial functions under hypoxic conditions: the steady state of cytochrome reduction and of energy metabolism. Biochem. Biophys. Acta., 347: 340–358, 1974.
Swain JL, Sabina RL, McHale PA, Greenfield JC, Holmes EW. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog. Am. J. Physiol., 242 (11): H817 - H26, 1982.
Altura BM. Comparative cellular and pharmacological actions of neurohypophyseal hormones on smooth muscle. Fed. Proc., 36: 1840, 1977.
Cowley AW, Switzer S, Guinn M. Evidence and quantification of the vasopressin arterial pressure control system in dogs. Circ. Res., 46: 48–67, 1980.
Montani JP, Liard JF, Schoun J, Mohring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentration in conscious dogs. Circ. Res., 47: 346–55, 1980.
Liard JF, Deriaz O, Schelling P, Thibonnier M. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. Am. J. Physio., 243: H663–9, 1982.
Cochrane JPS, Forsling ML, Menzies Gow N, Le Quesne LP. Arginine vasopressin release following surgical operations. Br. J. Surg., 68: 209–213, 1981.
Goldsmith SR, Francis GS, Cowley AW, Cohn JN. Response of vasopressin and norepinephrine to lower body negative pressure in humans. Am. J. Physiol., 243: H970 - H973, 1982.
Heyes MP, Fraber MO, Manfredi F, Robertshaw D, Weinberger M, Fineberg N, Robertson G. Acute effects of hypoxia on renal and endocrine function in normal humans. Am. J. Physiol. 243: R265 - R270, 1982.
Cowley AW, Cushman WC, Quillen EW, Skelton MM, Langford HG. Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake. Hypertension, 3 (1): I93 - I100, 1981.
Thibonnier M, Aldigier JC, Soto ME, Sassano P, Menard J, Corvol P. Abnormalities and drug-induced alterations of vaso-pression in human hypertension. Clin. Science, 61: 1495–152S, 1981.
Thibonnier M, Soto ME, Menard J, Aldiger JC, Corvol P, Milliez P. Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril. Eur. J. Clin. Invest., 11: 449–453, 1981.
Padfield PL. Vasopressin in hypertension. Amer. Heart J., 94: 531, 1978.
Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J. Am. Coll. Cardio., 1(6), 138590, 1983.
Vaziri ND, Skowsky R, Saiki J. Antidiuretic hormone in end-stage renal disease. J. Dialysis., 4 (2and3): 73–81, 1980.
Shimamoto K, Watarai I, Miyahara M. A study of plasma vasopressin in patients undergoing chronic hemodialysis. J. Clin. Endocrinol. Metab., 45: 714, 1977.
Klingenberg M. Nicotinamide-adenine denucleotides (NAD, NADP, NADH, NADPH); spectrophotometric and fluorimetric methods, H.U. Bergmeyer (ed), Methods of Enzymatic Analysis (2nd edition) New York, Academic Press, Inc., 4:2045–2059, 1974.
Wilkenson JH. LDH1, (2-hydroxybutyrate dehydrogenase) UV-assay. In H.U. Bergmeyer (ed), Methods of Enzymatic Analysis (2nd edition), New York, Academic Press, Inc., 2:603–612, 1974.
Baron DW, Walls JT, Anderson RE, Harrison CE. Protective effect of lidocaine during regional myocardial ischemia, an altered pathophysiologic response assessed by NADH fluorescence. Mayo Clin. Proc., 57: 442–447, 1982.
Burch HB, Lowry OH, Von Dippe P. The stability of triphosphopyridine nucleotide and its reduced form in rat liver. J. Biol. Chem., 238 (8): 2838–2842, 1963.
Bourke E, Rogers A, Guntipalli J. Studies on the antiphosphaturic action of insulin (I) independent of parathyroid hormone (PTH). Clin. Research, 31 (2), 1983.
Jennings RB, Hawkins HK, Lowe JE, Hill ML, Klotman S, Reimer, KA. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am. J. Pathol., 92: 187–214, 1978.
Jennings RB, Reimer KA, Hill ML, Mayer SE. Total ischemia in dog hearts, in vitro. 1. Comparison of high energy phosphate production, utilization and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo. Circ. Res., 49: 892–900, 1981.
Reimer KA, Jennings RB, Hill ML. Total ischemia in dog hearts, in vitro. 2. High energy phosphate depletion and associated defects in energy metabolism, cell volume regulation, and sarcolemmal integrity. Circ. Res., 49: 901–911, 1981.
Henry PD, Schuchleib R, Davis J, Weiss ES, Sobel BE. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am. J. Physiol., 233 (6): H677 - H684, 1977.
Shen AC, Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemic injury. Am. J. Pathol., 67: 441–452, 1972.
Bolling SF, Schirmer WJ, Gott VL, Flaherty JT, Bulkley BH, Gardner TJ. Enhanced myocardial protection with verapamil prior to postischemic reflow. Surgery, 283–290, August 1983.
Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am. J. Cardiol., 46: 242–248, 1980.
Rosenberger LB, Jacobs LW, Stanton HC. Evaluation of cardiac anoxia and ischemia models in the rat using calicum antagonists. Life Sci., 34: 1379–1387, 1984.
Aukland K, Kirg J. Renal oxygen tension. Nature, 188: 671, 1960.
Epstein FH, Balaban, Ross BD. Redox state of cytochrom aa3 in isolated perfused rat kidney. Am. J. Physiol., 243: F356 - F363, 1982.
Frega NS, DiBona DR, Guertler B, Leaf A. Ischemic renal injury. Kidney Int., 10: S17 - S25, 1976.
Venkatachalam MA, Bernard DB, Donohoe JF, Levinsky NG. Ischemic damage and repair in the rat proximal tubule: differences among the Sl, S2 and S3 segments. Kidney Int., 14: 31–49, 1978.
Kanda K, Flaim S. Effects of nifedipine on total cardiac output distribution in conscious rat. J. Pharm. Exp. Ther., 228: 711–718, 1984.
Humes HD, Simmons CF, Brenner BM. Effect of verapamil on the hydroosmotic response to antidiuretic hormone in toal urinary bladder. Am. J. Physiol., 239: F250 - F257, 1980.
Dantzler WH, Brokl OH. Verapamil and quinidine effects on PAH transport by isolated perfused renal tubules. Am. J. Physiol., 246: F188 - F200, 1984.
Hof RP. Selective effects of different calcium antagonists on the peripheral circulation. TIPS, 100–102, 1984.
Flaim SF, Zelis R. Effects of diltiazem on total cardiac output distribution in conscious rats. J. Pharm. Exp. Ther., 222: 359–366, 1982.
Goldfarb D, Iaina A, Serban I, Gavendo S, Kapuler S, Eliahou E. Beneficial effect of verapamil in ischemic acute renal failure in the rat. Proc. Soc. Exp. Biol. Med., 172: 389–392, 1983
Malls CD, Cheung JY, Leaf A, Bonventre HV. Effects of verapamil in models of ischemic acute renal failure in the rat. Am. J. Physiol., 245: F735–742, 1983.
Eliahou HE, Brodman RR, Friedman EA. Adrenergic blockers in ischemic acute renal failure in the rat. Proceedings of the Conference on Acute Renal Failure DHEW publication No. (NIH) 74–608, New York, 265–280, 1973.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
DiPette, D., Townsend, R., Guntipalli, J., Simpson, K., Rogers, A., Bourke, E. (1986). Effect of Calcium Antagonists on Vasopressin Induced Changes in Myocardial and Renal Pyridine Nucleotides in the Intact Rat. In: Brautbar, N. (eds) Myocardial and Skeletal Muscle Bioenergetics. Advances in Experimental Medicine and Biology, vol 194. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5107-8_38
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5107-8_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5109-2
Online ISBN: 978-1-4684-5107-8
eBook Packages: Springer Book Archive